SCA Pharma

SCA Pharma stands as a nationally recognized leader within the FDA 503B outsourcing sector, specializing in the provision of high-quality sterile admixture services and pre-filled syringes tailored for hospital and healthcare facility pharmacies. Founded in 2009, the company has established a robust operational framework to serve all therapeutic areas, including critical care, labor and delivery, anesthesia, and pain management. Its extensive product portfolio encompasses ready-to-use medications and solutions for drug shortages, underscoring a commitment to patient care and pharmaceutical supply chain integrity. With a revenue of $146.9M and an employee range of 500 - 1,000 individuals, SCA Pharma demonstrates significant operational scale and capacity.

The company's dedication to quality is evident in its comprehensive monitoring programs, including environmental controls and rigorous quality assurance protocols, ensuring compliance with stringent regulatory standards. This focus on best-in-class service delivery is supported by a skilled workforce, and for those interested in the human capital driving these operations, Meet SCA Pharma's team offers insights into their leadership and expertise. SCA Pharma's strategic approach involves leveraging advanced compounding techniques and maintaining a high standard of talent acquisition and development to meet the evolving needs of the healthcare industry.

Operating within the competitive Pharmaceuticals and Healthcare industries, SCA Pharma competes with entities such as CAPS, Quva, and Nephron, among others. Its market presence is characterized by a broad range of pharmaceutical outsourcing solutions designed to enhance pharmacy efficiency and patient safety. The company's four locations further support its extensive service reach across North America. SCA Pharma's business model isView more...